Digipharm (DPH): leveraging the blockchanin to maximaize Healthcare Delivery

The healthcare Industry globally has been faced with the challenge of providing the best possible medical support to patients while considering the lean purse many have, this has limited the patients access to quality healthcare services. The inefficient method of predicting the worth of new drugs and determining what the value of a pharmaceutical product should be in the market by Healthcare systems calls for a restructure in the valued-based healthcare delivery.
Traditional methods of tracking real world evidence in this sector limit the benefits of having a comprehensive and accurate data on healthcare delivery which is essential in value-based healthcare management system.
Digipharm (DPH) aims at providing solutions to the problem of data management in the healthcare industry by developing an independent Real World Evidence (RWE) platform that collates data between the manufacturer, provider (healthcare systems) and the patients, and automate the value-based pricing agreement. This in turn will facilitate reimbursements to manufactures on a “fee for performance” basis and ultimately boost the outcome of patients. Web: https://www.digiphram.ch
Through “Insights” platform and an incentivised patient feedback solution, Digipharm will provide the world’s first live RWE database. With a “live” evidence databank, the healthcare industry will witness speedy processes in decision making, improve in drug development and medical research. Digipharm will also foster the development of Personalized Healthcare services through tailored therapies which were before now an exception.
The ecosystem of Dipipharm is security, risk and privacy proven because of its adoption of the innovative blockchain technology, providing a range of solutions to innovative pricing and reimbursement to manufactures through its “Reimburse” platform. More details on Digipharm’s solutions to the healthcare industry is on their whitepaper here https://www.digiphram.ch/docs/Digipharm.pdf
The Digipharm platform is basically divided into two:
The INSIGHTS platform and the REIMBURSE platform for patients and manufactures respectively, DPH aims at reorganizing the healthcare sector by acting as the link between the HealthCare providers, manufactures of drugs and the patient. A schematic representation of the DPH network is shown below.
DPH will be utilizing features of the blockchain technology like Smart contracts, Private Channels and Digital Identity Services to provide an economic system that is safe, confidential and cost effective.
DPH 1.PNG
Benefits of the DPH network
To patients:
 Receive incentives for contributing to Insights database
 Control and ownership of their health data
 Security and confidentiality of data transfer
 Eliminates the cost of setting up a patient registery
To manufactures:
 Provides access to RWE at any time with speed
 Eliminates risk of running trial execution
 No more long and expensive observational studies
 Minimization of cost of buying data from conventional source.
To Providers:
 Avenue to provide better qualiry care through a value-based system
 An up to date method of service delivery
 Less burdensome to practice.
Digipharm token (DPH)
Within the platform DPH tokens will be used as the means of exchange to initiate smart contracts in the Reimburse module or as ‘access rights” on the insights module.
Distribution and sale
DPH 2.PNG
Token Characteristics
Type: ERC-20
Price: 1DPH = 1 USD Ticker code: DPH
Supply: 100milliom DPH Decimal place: 18
https://bitcointalk.org/index.php?action=profile;u=1156227
Wallet Address:  0x5fAcAaDD40AE912Dccf963096BCb530c413839EE 

Comments

Post a Comment